nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—HTR2A—pancreatitis	0.417	0.594	CbGaD
Fluoxetine—ALB—pancreatitis	0.285	0.406	CbGaD
Fluoxetine—Salivation—Propantheline—pancreatitis	0.00942	0.0469	CcSEcCtD
Fluoxetine—Cinacalcet—CASR—pancreatitis	0.00771	0.897	CrCbGaD
Fluoxetine—ORM1—bile—pancreatitis	0.00728	0.296	CbGeAlD
Fluoxetine—Accommodation disorder—Propantheline—pancreatitis	0.00636	0.0316	CcSEcCtD
Fluoxetine—Stridor—Hyoscyamine—pancreatitis	0.00574	0.0285	CcSEcCtD
Fluoxetine—Mydriasis—Propantheline—pancreatitis	0.00458	0.0228	CcSEcCtD
Fluoxetine—Hyperreflexia—Hyoscyamine—pancreatitis	0.00405	0.0201	CcSEcCtD
Fluoxetine—Salivary hypersecretion—Propantheline—pancreatitis	0.00355	0.0176	CcSEcCtD
Fluoxetine—Balance disorder—Hyoscyamine—pancreatitis	0.00342	0.017	CcSEcCtD
Fluoxetine—Accommodation disorder—Hyoscyamine—pancreatitis	0.00326	0.0162	CcSEcCtD
Fluoxetine—Blepharitis—Hyoscyamine—pancreatitis	0.00304	0.0151	CcSEcCtD
Fluoxetine—Thirst—Propantheline—pancreatitis	0.00279	0.0139	CcSEcCtD
Fluoxetine—Paranoia—Hyoscyamine—pancreatitis	0.00274	0.0136	CcSEcCtD
Fluoxetine—Paralysis—Hyoscyamine—pancreatitis	0.00269	0.0134	CcSEcCtD
Fluoxetine—Mania—Hyoscyamine—pancreatitis	0.00257	0.0128	CcSEcCtD
Fluoxetine—Ventricular arrhythmia—Hyoscyamine—pancreatitis	0.00253	0.0126	CcSEcCtD
Fluoxetine—Stupor—Hyoscyamine—pancreatitis	0.0025	0.0125	CcSEcCtD
Fluoxetine—Ventricular fibrillation—Hyoscyamine—pancreatitis	0.00244	0.0121	CcSEcCtD
Fluoxetine—Mydriasis—Hyoscyamine—pancreatitis	0.00234	0.0117	CcSEcCtD
Fluoxetine—Ageusia—Hyoscyamine—pancreatitis	0.00231	0.0115	CcSEcCtD
Fluoxetine—Abdominal distension—Propantheline—pancreatitis	0.00231	0.0115	CcSEcCtD
Fluoxetine—Dysphagia—Propantheline—pancreatitis	0.00229	0.0114	CcSEcCtD
Fluoxetine—Petechiae—Hyoscyamine—pancreatitis	0.00227	0.0113	CcSEcCtD
Fluoxetine—Blood disorder—Hyoscyamine—pancreatitis	0.00224	0.0111	CcSEcCtD
Fluoxetine—Extrasystoles—Hyoscyamine—pancreatitis	0.00222	0.0111	CcSEcCtD
Fluoxetine—Delirium—Hyoscyamine—pancreatitis	0.00217	0.0108	CcSEcCtD
Fluoxetine—Erectile dysfunction—Propantheline—pancreatitis	0.00211	0.0105	CcSEcCtD
Fluoxetine—Ventricular extrasystoles—Hyoscyamine—pancreatitis	0.00207	0.0103	CcSEcCtD
Fluoxetine—Drowsiness—Propantheline—pancreatitis	0.00204	0.0102	CcSEcCtD
Fluoxetine—ORM1—gall bladder—pancreatitis	0.00202	0.082	CbGeAlD
Fluoxetine—Leukocytosis—Hyoscyamine—pancreatitis	0.00199	0.00989	CcSEcCtD
Fluoxetine—Dysarthria—Hyoscyamine—pancreatitis	0.00198	0.00983	CcSEcCtD
Fluoxetine—Respiratory failure—Hyoscyamine—pancreatitis	0.0019	0.00947	CcSEcCtD
Fluoxetine—Muscle twitching—Hyoscyamine—pancreatitis	0.0019	0.00947	CcSEcCtD
Fluoxetine—Ventricular tachycardia—Hyoscyamine—pancreatitis	0.00187	0.0093	CcSEcCtD
Fluoxetine—Blood pressure increased—Hyoscyamine—pancreatitis	0.00187	0.0093	CcSEcCtD
Fluoxetine—Dermatitis contact—Hyoscyamine—pancreatitis	0.00185	0.00919	CcSEcCtD
Fluoxetine—Depressed level of consciousness—Hyoscyamine—pancreatitis	0.00181	0.00898	CcSEcCtD
Fluoxetine—ALB—gall bladder—pancreatitis	0.00177	0.0719	CbGeAlD
Fluoxetine—Blood urea increased—Hyoscyamine—pancreatitis	0.00177	0.00878	CcSEcCtD
Fluoxetine—Photophobia—Hyoscyamine—pancreatitis	0.00176	0.00873	CcSEcCtD
Fluoxetine—Dry eye—Hyoscyamine—pancreatitis	0.00173	0.00859	CcSEcCtD
Fluoxetine—Coma—Hyoscyamine—pancreatitis	0.00171	0.0085	CcSEcCtD
Fluoxetine—Rash maculo-papular—Hyoscyamine—pancreatitis	0.0017	0.00845	CcSEcCtD
Fluoxetine—Pulmonary oedema—Hyoscyamine—pancreatitis	0.00166	0.00828	CcSEcCtD
Fluoxetine—Hypertonia—Hyoscyamine—pancreatitis	0.00164	0.00815	CcSEcCtD
Fluoxetine—Hyperkinesia—Hyoscyamine—pancreatitis	0.00163	0.00811	CcSEcCtD
Fluoxetine—Tension—Propantheline—pancreatitis	0.00157	0.00779	CcSEcCtD
Fluoxetine—Nervousness—Propantheline—pancreatitis	0.00155	0.00771	CcSEcCtD
Fluoxetine—Eczema—Hyoscyamine—pancreatitis	0.00151	0.00751	CcSEcCtD
Fluoxetine—Eye pain—Hyoscyamine—pancreatitis	0.0015	0.00748	CcSEcCtD
Fluoxetine—Amnesia—Hyoscyamine—pancreatitis	0.00144	0.00718	CcSEcCtD
Fluoxetine—Atrial fibrillation—Hyoscyamine—pancreatitis	0.00143	0.00712	CcSEcCtD
Fluoxetine—Thirst—Hyoscyamine—pancreatitis	0.00143	0.00709	CcSEcCtD
Fluoxetine—Palpitations—Propantheline—pancreatitis	0.00141	0.00702	CcSEcCtD
Fluoxetine—Hypoglycaemia—Hyoscyamine—pancreatitis	0.00139	0.00692	CcSEcCtD
Fluoxetine—Lethargy—Hyoscyamine—pancreatitis	0.00139	0.00689	CcSEcCtD
Fluoxetine—Hyponatraemia—Hyoscyamine—pancreatitis	0.00136	0.00678	CcSEcCtD
Fluoxetine—Osteoarthritis—Hyoscyamine—pancreatitis	0.00136	0.00675	CcSEcCtD
Fluoxetine—Dry mouth—Propantheline—pancreatitis	0.00133	0.00661	CcSEcCtD
Fluoxetine—Psychotic disorder—Hyoscyamine—pancreatitis	0.00133	0.00659	CcSEcCtD
Fluoxetine—Confusional state—Propantheline—pancreatitis	0.00131	0.00653	CcSEcCtD
Fluoxetine—Anaphylactic shock—Propantheline—pancreatitis	0.0013	0.00648	CcSEcCtD
Fluoxetine—Irritability—Hyoscyamine—pancreatitis	0.0013	0.00644	CcSEcCtD
Fluoxetine—Cardiac arrest—Hyoscyamine—pancreatitis	0.00129	0.00642	CcSEcCtD
Fluoxetine—Urinary retention—Hyoscyamine—pancreatitis	0.00129	0.00642	CcSEcCtD
Fluoxetine—Ataxia—Hyoscyamine—pancreatitis	0.00128	0.00635	CcSEcCtD
Fluoxetine—Tachycardia—Propantheline—pancreatitis	0.00127	0.00633	CcSEcCtD
Fluoxetine—Dehydration—Hyoscyamine—pancreatitis	0.00126	0.00628	CcSEcCtD
Fluoxetine—Dry skin—Hyoscyamine—pancreatitis	0.00124	0.00619	CcSEcCtD
Fluoxetine—Hypokalaemia—Hyoscyamine—pancreatitis	0.00124	0.00614	CcSEcCtD
Fluoxetine—Abdominal distension—Hyoscyamine—pancreatitis	0.00118	0.00587	CcSEcCtD
Fluoxetine—Insomnia—Propantheline—pancreatitis	0.00118	0.00586	CcSEcCtD
Fluoxetine—Dysphagia—Hyoscyamine—pancreatitis	0.00117	0.00583	CcSEcCtD
Fluoxetine—Somnolence—Propantheline—pancreatitis	0.00116	0.00576	CcSEcCtD
Fluoxetine—Angina pectoris—Hyoscyamine—pancreatitis	0.00114	0.00568	CcSEcCtD
Fluoxetine—SIGMAR1—islet of Langerhans—pancreatitis	0.00112	0.0455	CbGeAlD
Fluoxetine—Constipation—Propantheline—pancreatitis	0.00111	0.00554	CcSEcCtD
Fluoxetine—Dysuria—Hyoscyamine—pancreatitis	0.0011	0.00546	CcSEcCtD
Fluoxetine—Erectile dysfunction—Hyoscyamine—pancreatitis	0.00108	0.00537	CcSEcCtD
Fluoxetine—Feeling abnormal—Propantheline—pancreatitis	0.00107	0.00534	CcSEcCtD
Fluoxetine—Hyperglycaemia—Hyoscyamine—pancreatitis	0.00106	0.00526	CcSEcCtD
Fluoxetine—Drowsiness—Hyoscyamine—pancreatitis	0.00105	0.0052	CcSEcCtD
Fluoxetine—Depression—Hyoscyamine—pancreatitis	0.00104	0.00519	CcSEcCtD
Fluoxetine—Urticaria—Propantheline—pancreatitis	0.00104	0.00515	CcSEcCtD
Fluoxetine—Acute coronary syndrome—Hyoscyamine—pancreatitis	0.00103	0.00513	CcSEcCtD
Fluoxetine—Myocardial infarction—Hyoscyamine—pancreatitis	0.00103	0.0051	CcSEcCtD
Fluoxetine—Conjunctivitis—Hyoscyamine—pancreatitis	0.00102	0.00506	CcSEcCtD
Fluoxetine—Sweating—Hyoscyamine—pancreatitis	0.001	0.00499	CcSEcCtD
Fluoxetine—Hypersensitivity—Propantheline—pancreatitis	0.00096	0.00477	CcSEcCtD
Fluoxetine—Bradycardia—Hyoscyamine—pancreatitis	0.000956	0.00475	CcSEcCtD
Fluoxetine—Asthenia—Propantheline—pancreatitis	0.000935	0.00465	CcSEcCtD
Fluoxetine—Hallucination—Hyoscyamine—pancreatitis	0.000934	0.00465	CcSEcCtD
Fluoxetine—Dizziness—Propantheline—pancreatitis	0.000862	0.00429	CcSEcCtD
Fluoxetine—Arrhythmia—Hyoscyamine—pancreatitis	0.000839	0.00417	CcSEcCtD
Fluoxetine—Vomiting—Propantheline—pancreatitis	0.000829	0.00412	CcSEcCtD
Fluoxetine—Mental disorder—Hyoscyamine—pancreatitis	0.000823	0.00409	CcSEcCtD
Fluoxetine—Rash—Propantheline—pancreatitis	0.000822	0.00409	CcSEcCtD
Fluoxetine—Dermatitis—Propantheline—pancreatitis	0.000821	0.00408	CcSEcCtD
Fluoxetine—Headache—Propantheline—pancreatitis	0.000816	0.00406	CcSEcCtD
Fluoxetine—Tension—Hyoscyamine—pancreatitis	0.000802	0.00399	CcSEcCtD
Fluoxetine—Dysgeusia—Hyoscyamine—pancreatitis	0.0008	0.00398	CcSEcCtD
Fluoxetine—Nervousness—Hyoscyamine—pancreatitis	0.000794	0.00395	CcSEcCtD
Fluoxetine—SIGMAR1—pancreas—pancreatitis	0.000788	0.032	CbGeAlD
Fluoxetine—Nausea—Propantheline—pancreatitis	0.000774	0.00385	CcSEcCtD
Fluoxetine—ORM1—blood—pancreatitis	0.000758	0.0308	CbGeAlD
Fluoxetine—Agitation—Hyoscyamine—pancreatitis	0.000751	0.00374	CcSEcCtD
Fluoxetine—Angioedema—Hyoscyamine—pancreatitis	0.000747	0.00371	CcSEcCtD
Fluoxetine—CYP3A5—islet of Langerhans—pancreatitis	0.000737	0.0299	CbGeAlD
Fluoxetine—Vertigo—Hyoscyamine—pancreatitis	0.000734	0.00365	CcSEcCtD
Fluoxetine—Syncope—Hyoscyamine—pancreatitis	0.000733	0.00365	CcSEcCtD
Fluoxetine—Palpitations—Hyoscyamine—pancreatitis	0.000722	0.00359	CcSEcCtD
Fluoxetine—Loss of consciousness—Hyoscyamine—pancreatitis	0.000718	0.00357	CcSEcCtD
Fluoxetine—Convulsion—Hyoscyamine—pancreatitis	0.000708	0.00352	CcSEcCtD
Fluoxetine—Chest pain—Hyoscyamine—pancreatitis	0.000696	0.00346	CcSEcCtD
Fluoxetine—Anxiety—Hyoscyamine—pancreatitis	0.000693	0.00345	CcSEcCtD
Fluoxetine—Dry mouth—Hyoscyamine—pancreatitis	0.000681	0.00338	CcSEcCtD
Fluoxetine—SLC6A4—digestive system—pancreatitis	0.000678	0.0275	CbGeAlD
Fluoxetine—Confusional state—Hyoscyamine—pancreatitis	0.000673	0.00335	CcSEcCtD
Fluoxetine—Anaphylactic shock—Hyoscyamine—pancreatitis	0.000667	0.00332	CcSEcCtD
Fluoxetine—Shock—Hyoscyamine—pancreatitis	0.000656	0.00326	CcSEcCtD
Fluoxetine—Tachycardia—Hyoscyamine—pancreatitis	0.000651	0.00324	CcSEcCtD
Fluoxetine—SLC6A4—blood—pancreatitis	0.000646	0.0262	CbGeAlD
Fluoxetine—Hyperhidrosis—Hyoscyamine—pancreatitis	0.000645	0.00321	CcSEcCtD
Fluoxetine—SIGMAR1—blood—pancreatitis	0.000641	0.026	CbGeAlD
Fluoxetine—Hypotension—Hyoscyamine—pancreatitis	0.000623	0.0031	CcSEcCtD
Fluoxetine—Insomnia—Hyoscyamine—pancreatitis	0.000603	0.003	CcSEcCtD
Fluoxetine—Dyspnoea—Hyoscyamine—pancreatitis	0.000595	0.00296	CcSEcCtD
Fluoxetine—Somnolence—Hyoscyamine—pancreatitis	0.000593	0.00295	CcSEcCtD
Fluoxetine—Dyspepsia—Hyoscyamine—pancreatitis	0.000587	0.00292	CcSEcCtD
Fluoxetine—Duloxetine—HTR2A—pancreatitis	0.000579	0.0674	CrCbGaD
Fluoxetine—Fatigue—Hyoscyamine—pancreatitis	0.000575	0.00286	CcSEcCtD
Fluoxetine—Constipation—Hyoscyamine—pancreatitis	0.00057	0.00284	CcSEcCtD
Fluoxetine—Pain—Hyoscyamine—pancreatitis	0.00057	0.00284	CcSEcCtD
Fluoxetine—CYP2C19—digestive system—pancreatitis	0.000561	0.0228	CbGeAlD
Fluoxetine—Feeling abnormal—Hyoscyamine—pancreatitis	0.00055	0.00273	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.000545	0.00271	CcSEcCtD
Fluoxetine—CYP2C19—blood—pancreatitis	0.000535	0.0217	CbGeAlD
Fluoxetine—Urticaria—Hyoscyamine—pancreatitis	0.00053	0.00264	CcSEcCtD
Fluoxetine—Body temperature increased—Hyoscyamine—pancreatitis	0.000527	0.00262	CcSEcCtD
Fluoxetine—Abdominal pain—Hyoscyamine—pancreatitis	0.000527	0.00262	CcSEcCtD
Fluoxetine—CYP3A5—pancreas—pancreatitis	0.000518	0.021	CbGeAlD
Fluoxetine—Hypersensitivity—Hyoscyamine—pancreatitis	0.000491	0.00244	CcSEcCtD
Fluoxetine—Asthenia—Hyoscyamine—pancreatitis	0.000479	0.00238	CcSEcCtD
Fluoxetine—Pruritus—Hyoscyamine—pancreatitis	0.000472	0.00235	CcSEcCtD
Fluoxetine—CYP1A2—digestive system—pancreatitis	0.000459	0.0186	CbGeAlD
Fluoxetine—Diarrhoea—Hyoscyamine—pancreatitis	0.000456	0.00227	CcSEcCtD
Fluoxetine—CYP3A5—digestive system—pancreatitis	0.000442	0.018	CbGeAlD
Fluoxetine—Dizziness—Hyoscyamine—pancreatitis	0.000441	0.00219	CcSEcCtD
Fluoxetine—CYP2B6—digestive system—pancreatitis	0.00044	0.0178	CbGeAlD
Fluoxetine—CYP1A2—blood—pancreatitis	0.000437	0.0177	CbGeAlD
Fluoxetine—CYP2C9—digestive system—pancreatitis	0.000435	0.0177	CbGeAlD
Fluoxetine—Vomiting—Hyoscyamine—pancreatitis	0.000424	0.00211	CcSEcCtD
Fluoxetine—CYP3A5—blood—pancreatitis	0.000421	0.0171	CbGeAlD
Fluoxetine—Rash—Hyoscyamine—pancreatitis	0.000421	0.00209	CcSEcCtD
Fluoxetine—Dermatitis—Hyoscyamine—pancreatitis	0.00042	0.00209	CcSEcCtD
Fluoxetine—CYP2B6—blood—pancreatitis	0.000419	0.017	CbGeAlD
Fluoxetine—Headache—Hyoscyamine—pancreatitis	0.000418	0.00208	CcSEcCtD
Fluoxetine—CYP2C9—blood—pancreatitis	0.000415	0.0168	CbGeAlD
Fluoxetine—Nausea—Hyoscyamine—pancreatitis	0.000396	0.00197	CcSEcCtD
Fluoxetine—ABCB1—islet of Langerhans—pancreatitis	0.000391	0.0159	CbGeAlD
Fluoxetine—HTR2A—digestive system—pancreatitis	0.000359	0.0146	CbGeAlD
Fluoxetine—HTR2A—blood—pancreatitis	0.000342	0.0139	CbGeAlD
Fluoxetine—CYP3A4—digestive system—pancreatitis	0.000332	0.0135	CbGeAlD
Fluoxetine—CYP2D6—digestive system—pancreatitis	0.000327	0.0133	CbGeAlD
Fluoxetine—CYP3A4—blood—pancreatitis	0.000316	0.0128	CbGeAlD
Fluoxetine—CYP2D6—blood—pancreatitis	0.000311	0.0126	CbGeAlD
Fluoxetine—Atomoxetine—HTR2A—pancreatitis	0.000303	0.0353	CrCbGaD
Fluoxetine—ABCB1—pancreas—pancreatitis	0.000275	0.0112	CbGeAlD
Fluoxetine—ABCB1—digestive system—pancreatitis	0.000235	0.00954	CbGeAlD
Fluoxetine—ABCB1—blood—pancreatitis	0.000224	0.00909	CbGeAlD
Fluoxetine—CYP2C19—Metabolism—PRSS1—pancreatitis	2.84e-05	0.000444	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—KNG1—pancreatitis	2.79e-05	0.000436	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—SCT—pancreatitis	2.78e-05	0.000436	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CASR—pancreatitis	2.78e-05	0.000436	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—FGG—pancreatitis	2.78e-05	0.000436	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—BDKRB2—pancreatitis	2.78e-05	0.000435	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ADH4—pancreatitis	2.77e-05	0.000434	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PRSS1—pancreatitis	2.77e-05	0.000433	CbGpPWpGaD
Fluoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatitis	2.75e-05	0.00043	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ADH4—pancreatitis	2.75e-05	0.00043	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CNR1—pancreatitis	2.73e-05	0.000427	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CX3CL1—pancreatitis	2.73e-05	0.000427	CbGpPWpGaD
Fluoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatitis	2.69e-05	0.000421	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PRSS3—pancreatitis	2.69e-05	0.000421	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PNLIP—pancreatitis	2.69e-05	0.000421	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—XDH—pancreatitis	2.69e-05	0.00042	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CCL5—pancreatitis	2.68e-05	0.00042	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CCK—pancreatitis	2.66e-05	0.000416	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—MTNR1B—pancreatitis	2.66e-05	0.000416	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—HGF—pancreatitis	2.64e-05	0.000413	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—GCG—pancreatitis	2.64e-05	0.000413	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatitis	2.64e-05	0.000413	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PRSS3—pancreatitis	2.62e-05	0.000411	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PNLIP—pancreatitis	2.62e-05	0.000411	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PRSS1—pancreatitis	2.61e-05	0.000408	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—A2M—pancreatitis	2.59e-05	0.000405	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CNR2—pancreatitis	2.59e-05	0.000405	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TACR1—pancreatitis	2.59e-05	0.000405	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—CXCL8—pancreatitis	2.59e-05	0.000405	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PRSS1—pancreatitis	2.59e-05	0.000405	CbGpPWpGaD
Fluoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—pancreatitis	2.58e-05	0.000403	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CCKAR—pancreatitis	2.55e-05	0.000398	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—KNG1—pancreatitis	2.53e-05	0.000396	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—FDX1—pancreatitis	2.53e-05	0.000396	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ADH1B—pancreatitis	2.51e-05	0.000392	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PNLIP—pancreatitis	2.47e-05	0.000387	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PRSS3—pancreatitis	2.47e-05	0.000387	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PRSS3—pancreatitis	2.45e-05	0.000384	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PNLIP—pancreatitis	2.45e-05	0.000384	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CCL5—pancreatitis	2.44e-05	0.000381	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—SCT—pancreatitis	2.42e-05	0.000378	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—FGG—pancreatitis	2.42e-05	0.000378	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CASR—pancreatitis	2.42e-05	0.000378	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—XDH—pancreatitis	2.41e-05	0.000377	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PLA2G1B—pancreatitis	2.37e-05	0.000371	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CX3CL1—pancreatitis	2.37e-05	0.000371	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—FGA—pancreatitis	2.37e-05	0.00037	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—HTR2A—pancreatitis	2.37e-05	0.00037	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—LPL—pancreatitis	2.36e-05	0.000369	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—XDH—pancreatitis	2.35e-05	0.000368	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ADH4—pancreatitis	2.35e-05	0.000368	CbGpPWpGaD
Fluoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatitis	2.34e-05	0.000366	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CCL5—pancreatitis	2.33e-05	0.000365	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PLA2G1B—pancreatitis	2.32e-05	0.000363	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCK—pancreatitis	2.31e-05	0.000361	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—MTNR1B—pancreatitis	2.31e-05	0.000361	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—A2M—pancreatitis	2.29e-05	0.000359	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CTRB2—pancreatitis	2.25e-05	0.000352	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ADH1B—pancreatitis	2.25e-05	0.000352	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CNR2—pancreatitis	2.25e-05	0.000352	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—A2M—pancreatitis	2.25e-05	0.000352	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TACR1—pancreatitis	2.25e-05	0.000352	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—CXCL8—pancreatitis	2.25e-05	0.000351	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—A2M—pancreatitis	2.24e-05	0.000351	CbGpPWpGaD
Fluoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—pancreatitis	2.24e-05	0.00035	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—XDH—pancreatitis	2.22e-05	0.000347	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCKAR—pancreatitis	2.21e-05	0.000346	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PRSS1—pancreatitis	2.21e-05	0.000346	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—PTHLH—pancreatitis	2.2e-05	0.000344	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—SMO—pancreatitis	2.2e-05	0.000344	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—XDH—pancreatitis	2.2e-05	0.000344	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ADH1B—pancreatitis	2.2e-05	0.000343	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—FGB—pancreatitis	2.15e-05	0.000337	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—HTR2A—pancreatitis	2.15e-05	0.000336	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CCL5—pancreatitis	2.12e-05	0.000331	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—pancreatitis	2.12e-05	0.000331	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—PPP3CA—pancreatitis	2.1e-05	0.000329	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ALDH2—pancreatitis	2.1e-05	0.000328	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PNLIP—pancreatitis	2.1e-05	0.000328	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PRSS3—pancreatitis	2.1e-05	0.000328	CbGpPWpGaD
Fluoxetine—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatitis	2.09e-05	0.000326	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ADH1B—pancreatitis	2.07e-05	0.000324	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—FGA—pancreatitis	2.06e-05	0.000322	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatitis	2.05e-05	0.000321	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ADH1B—pancreatitis	2.05e-05	0.000321	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ALDH2—pancreatitis	2.05e-05	0.000321	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—SST—pancreatitis	2.01e-05	0.000315	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PLA2G1B—pancreatitis	2e-05	0.000313	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—DUSP6—pancreatitis	2e-05	0.000312	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—FDX1—pancreatitis	1.95e-05	0.000305	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—A2M—pancreatitis	1.93e-05	0.000302	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—pancreatitis	1.93e-05	0.000302	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatitis	1.92e-05	0.0003	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PTHLH—pancreatitis	1.91e-05	0.000299	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—SMO—pancreatitis	1.91e-05	0.000299	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	1.9e-05	0.000298	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—BDKRB2—pancreatitis	1.89e-05	0.000296	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—XDH—pancreatitis	1.88e-05	0.000294	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—FGB—pancreatitis	1.87e-05	0.000293	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CNR1—pancreatitis	1.86e-05	0.000291	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PPP3CA—pancreatitis	1.82e-05	0.000285	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ADH4—pancreatitis	1.81e-05	0.000284	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—GCG—pancreatitis	1.79e-05	0.000281	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PLA2G1B—pancreatitis	1.79e-05	0.000281	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ALDH2—pancreatitis	1.77e-05	0.000276	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ADH1B—pancreatitis	1.75e-05	0.000274	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PLA2G1B—pancreatitis	1.75e-05	0.000274	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—SST—pancreatitis	1.75e-05	0.000273	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—DUSP6—pancreatitis	1.73e-05	0.000271	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—A2M—pancreatitis	1.73e-05	0.000271	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—KNG1—pancreatitis	1.72e-05	0.000269	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.72e-05	0.000269	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PRSS1—pancreatitis	1.71e-05	0.000267	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—A2M—pancreatitis	1.69e-05	0.000265	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CCL2—pancreatitis	1.68e-05	0.000263	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PLA2G1B—pancreatitis	1.65e-05	0.000258	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—pancreatitis	1.65e-05	0.000258	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—BDKRB2—pancreatitis	1.64e-05	0.000257	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PLA2G1B—pancreatitis	1.64e-05	0.000256	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PNLIP—pancreatitis	1.62e-05	0.000253	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PRSS3—pancreatitis	1.62e-05	0.000253	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CNR1—pancreatitis	1.61e-05	0.000252	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—A2M—pancreatitis	1.59e-05	0.000249	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—GCG—pancreatitis	1.59e-05	0.000249	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ALDH2—pancreatitis	1.58e-05	0.000248	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—PDGFA—pancreatitis	1.58e-05	0.000248	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—A2M—pancreatitis	1.58e-05	0.000247	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—GCG—pancreatitis	1.56e-05	0.000244	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—GCG—pancreatitis	1.55e-05	0.000243	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ALDH2—pancreatitis	1.55e-05	0.000242	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.55e-05	0.000242	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—KNG1—pancreatitis	1.5e-05	0.000234	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CXCL8—pancreatitis	1.46e-05	0.000229	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CCL2—pancreatitis	1.46e-05	0.000228	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ALDH2—pancreatitis	1.46e-05	0.000228	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—XDH—pancreatitis	1.45e-05	0.000227	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ALDH2—pancreatitis	1.44e-05	0.000226	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CCL5—pancreatitis	1.44e-05	0.000225	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.41e-05	0.00022	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—LPL—pancreatitis	1.41e-05	0.00022	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PLA2G1B—pancreatitis	1.4e-05	0.000219	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.39e-05	0.000217	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PDGFA—pancreatitis	1.38e-05	0.000215	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.35e-05	0.000212	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ADH1B—pancreatitis	1.35e-05	0.000212	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—A2M—pancreatitis	1.35e-05	0.000211	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GCG—pancreatitis	1.34e-05	0.000209	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—SPP1—pancreatitis	1.33e-05	0.000209	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CXCL8—pancreatitis	1.33e-05	0.000208	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—ALB—pancreatitis	1.29e-05	0.000202	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CXCL8—pancreatitis	1.27e-05	0.000199	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—HTR2A—pancreatitis	1.27e-05	0.000199	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.27e-05	0.000198	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCL5—pancreatitis	1.25e-05	0.000196	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—LPL—pancreatitis	1.25e-05	0.000195	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ALDH2—pancreatitis	1.23e-05	0.000193	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—LPL—pancreatitis	1.22e-05	0.000191	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—LPL—pancreatitis	1.22e-05	0.000191	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.22e-05	0.00019	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.2e-05	0.000188	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GCG—pancreatitis	1.2e-05	0.000188	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—LEP—pancreatitis	1.18e-05	0.000185	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GCG—pancreatitis	1.17e-05	0.000183	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—SPP1—pancreatitis	1.16e-05	0.000181	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—NRAS—pancreatitis	1.16e-05	0.000181	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CXCL8—pancreatitis	1.15e-05	0.00018	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.11e-05	0.000173	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GCG—pancreatitis	1.1e-05	0.000173	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GCG—pancreatitis	1.1e-05	0.000171	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.08e-05	0.000169	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PLA2G1B—pancreatitis	1.08e-05	0.000169	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—TGFB1—pancreatitis	1.08e-05	0.000168	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—NRAS—pancreatitis	1.07e-05	0.000167	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—LPL—pancreatitis	1.05e-05	0.000164	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—A2M—pancreatitis	1.04e-05	0.000163	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—LEP—pancreatitis	1.02e-05	0.00016	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—INS—pancreatitis	1.01e-05	0.000158	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—KRAS—pancreatitis	9.96e-06	0.000156	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CCL2—pancreatitis	9.92e-06	0.000155	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ALDH2—pancreatitis	9.53e-06	0.000149	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	9.47e-06	0.000148	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—LPL—pancreatitis	9.42e-06	0.000147	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GCG—pancreatitis	9.36e-06	0.000146	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—NRAS—pancreatitis	9.25e-06	0.000145	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—LPL—pancreatitis	9.2e-06	0.000144	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—KRAS—pancreatitis	9.17e-06	0.000143	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PPARG—pancreatitis	9.11e-06	0.000142	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—INS—pancreatitis	8.93e-06	0.00014	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PPARG—pancreatitis	8.9e-06	0.000139	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—INS—pancreatitis	8.75e-06	0.000137	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—INS—pancreatitis	8.73e-06	0.000137	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—LPL—pancreatitis	8.67e-06	0.000136	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCL2—pancreatitis	8.61e-06	0.000135	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—LPL—pancreatitis	8.59e-06	0.000134	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—HRAS—pancreatitis	8.47e-06	0.000132	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—MDM2—pancreatitis	8.39e-06	0.000131	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ALB—pancreatitis	8.19e-06	0.000128	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ALB—pancreatitis	8e-06	0.000125	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—KRAS—pancreatitis	7.96e-06	0.000125	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CXCL8—pancreatitis	7.84e-06	0.000123	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—HRAS—pancreatitis	7.79e-06	0.000122	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PPARG—pancreatitis	7.66e-06	0.00012	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—INS—pancreatitis	7.52e-06	0.000118	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CASP3—pancreatitis	7.51e-06	0.000117	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—IL6—pancreatitis	7.46e-06	0.000117	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—LPL—pancreatitis	7.34e-06	0.000115	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—MDM2—pancreatitis	7.28e-06	0.000114	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GCG—pancreatitis	7.22e-06	0.000113	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PTGS2—pancreatitis	7.16e-06	0.000112	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PTGS2—pancreatitis	7e-06	0.00011	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PPARG—pancreatitis	6.88e-06	0.000108	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CXCL8—pancreatitis	6.81e-06	0.000107	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—HRAS—pancreatitis	6.77e-06	0.000106	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—INS—pancreatitis	6.75e-06	0.000106	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PPARG—pancreatitis	6.72e-06	0.000105	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—INS—pancreatitis	6.59e-06	0.000103	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CASP3—pancreatitis	6.52e-06	0.000102	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—IL6—pancreatitis	6.48e-06	0.000101	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PPARG—pancreatitis	6.33e-06	9.9e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NRAS—pancreatitis	6.29e-06	9.84e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PPARG—pancreatitis	6.27e-06	9.82e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—INS—pancreatitis	6.21e-06	9.71e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ALB—pancreatitis	6.19e-06	9.68e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—INS—pancreatitis	6.15e-06	9.63e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ALB—pancreatitis	6.04e-06	9.45e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PTGS2—pancreatitis	6.03e-06	9.43e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TGFB1—pancreatitis	5.85e-06	9.15e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ALB—pancreatitis	5.69e-06	8.9e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—LPL—pancreatitis	5.67e-06	8.87e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ALB—pancreatitis	5.64e-06	8.83e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NRAS—pancreatitis	5.46e-06	8.55e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—KRAS—pancreatitis	5.42e-06	8.47e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PTGS2—pancreatitis	5.41e-06	8.47e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PPARG—pancreatitis	5.36e-06	8.39e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PTGS2—pancreatitis	5.28e-06	8.27e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—INS—pancreatitis	5.26e-06	8.23e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TGFB1—pancreatitis	5.08e-06	7.94e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PTGS2—pancreatitis	4.98e-06	7.79e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PTGS2—pancreatitis	4.94e-06	7.72e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ALB—pancreatitis	4.82e-06	7.54e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—KRAS—pancreatitis	4.7e-06	7.36e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—HRAS—pancreatitis	4.6e-06	7.2e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IL6—pancreatitis	4.41e-06	6.89e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PTGS2—pancreatitis	4.22e-06	6.6e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PPARG—pancreatitis	4.14e-06	6.47e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—INS—pancreatitis	4.06e-06	6.35e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—HRAS—pancreatitis	4e-06	6.25e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IL6—pancreatitis	3.83e-06	5.99e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ALB—pancreatitis	3.72e-06	5.82e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PTGS2—pancreatitis	3.25e-06	5.09e-05	CbGpPWpGaD
